BioSpace News Archive

Biotech Beach

Armata Pharmaceuticals Announces New Financing and Leadership Transition to Accelerate Novel Bacteriophage Therapeutics

Armata Pharmaceuticals, Inc. today announced that it has entered into a credit and security agreement with Innoviva Strategic Opportunities LLC, a wholly‐owned subsidiary of Innoviva, Inc. (Nasdaq: INVA) (collectively, “Innoviva”).

July 11, 2023
·
7 min read
Deals

Beacon Biosignals Acquires Dreem, Launches At-home Sleep Monitoring Services for Clinical Trials

Beacon Biosignals, the leading computational neurodiagnostics and electroencephalogram analytics company, is pleased to announce that it has completed the acquisition of the research and development business of Dreem, a Paris-based pioneer in at-home sleep monitoring.

July 11, 2023
·
4 min read
Business

BD Recognized as a Best Place to Work for Disability Inclusion

BD, a leading global medical technology company, announced its recognition as a Best Place to Work for Disability Inclusion for the fifth consecutive year.

July 11, 2023
·
3 min read
Business

Ratio Therapeutics, In Collaboration with Lantheus and PharmaLogic, Announce First Patient Dosed in Phase I Study Evaluating a Novel FAP-Targeted Radiopharmaceutical for PET Imaging

Ratio Therapeutics Inc. today announced, in partnership with Lantheus, a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions.

July 11, 2023
·
4 min read
Genetown

Acclaro Medical Unveils Rebranding of Flagship Product UltraClear Cold Fiber Laser, Paving the Way for Next-Level Innovation and Customer Engagement

Acclaro Medical, a trailblazer in the aesthetic medical laser sector, is pleased to announce the rebranding of its flagship product, UltraClear® Cold Fiber Laser.

July 11, 2023
·
3 min read
Pixium Vision announces the agreement to extend the maturity date of the outstanding notes associated with the terminated ESGO financing facility

Pixium Vision announces the agreement to extend the maturity date of the outstanding notes associated with the terminatedESGO financing facility

July 11, 2023
·
3 min read
U.S. National Institutes of Health to Fund $4.2 Million Contract to Advance Development of Pluri’s PLX-R18 in Conjunction with U.S. DoD as a Medical Countermeasure for Hematopoietic Acute Radiation Syndrome

Pluri Inc. announced that it has signed a three year $4.2M contract with the U.S. National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

July 11, 2023
·
9 min read
Drug Development

AlzeCure Publishes New Disease Modifying Data with NeuroRestore ACD856 Against Alzheimer’s and Cognitive Disorders

AlzeCure Pharma AB announced that a new scientific article has been published on NeuroRestore ACD856 and preclinical results supporting its disease-modifying effect.

July 11, 2023
·
6 min read
Business

Sosei Heptares Webinar Presentation for Q2 FY2023 Financial Results

Sosei Group Corporation will announce its earnings results and present operational highlights for the 6 months ended 30 June 2023 on Friday, 4 August 2023.

July 11, 2023
·
2 min read
Drug Development

Enterome announces first patient dosed in Phase 2 trial with OncoMimics™ immunotherapy EO2040 in Colorectal Cancer with ctDNA-defined Minimal Residual Disease

Enterome announces that the first patient has been dosed at The University of Texas MD Anderson Cancer Center in the Phase 2 ‘CLAUDE’ trial evaluating EO2040, the Company’s fourth OncoMimics™ immunotherapy candidate to enter clinical development.

July 11, 2023
·
6 min read